LIPO (OTC)
LIPELLA PHARMS INC
$0.205500
+0.013500 (+7.03%)
Prev close: $0.192000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jonathan Kaufman
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $1.97M
- Employees
- 7
- P/E (TTM)
- -3.97
- P/B (TTM)
- 1.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-1.19 | $-2.48 | +1.2886 | +51.99% |
|
Sep 2024 (Q3)
|
$-1.29 | $-0.98 | -0.3108 | -31.74% |
Financial Statements
| Nonoperating Income/Loss | $80.20K |
| Research and Development | $3.57M |
| Operating Income/Loss | -$5.41M |
| Income/Loss From Continuing Operations After Tax | -$5.33M |
| Income/Loss From Continuing Operations Before Tax | -$5.33M |
| Net Income/Loss | -$5.33M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$5.33M |
| Net Income/Loss Available To Common Stockholders, Basic | -$5.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.26 |
| Diluted Earnings Per Share | -$2.26 |
| Basic Average Shares | 3,700,118 |
| Diluted Average Shares | 3,700,118 |
| Assets | $2.35M |
| Current Assets | $2.08M |
| Prepaid Expenses | $223.52K |
| Other Current Assets | $1.86M |
| Noncurrent Assets | $270.52K |
| Fixed Assets | $7.70K |
| Other Non-current Assets | $262.82K |
| Liabilities | $862.22K |
| Current Liabilities | $642.40K |
| Accounts Payable | $462.89K |
| Other Current Liabilities | $179.51K |
| Noncurrent Liabilities | $219.82K |
| Equity | $1.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.49M |
| Liabilities And Equity | $2.35M |
| Net Cash Flow From Operating Activities | -$4.78M |
| Net Cash Flow From Operating Activities, Continuing | -$4.78M |
| Net Cash Flow From Investing Activities | -$502.03K |
| Net Cash Flow From Investing Activities, Continuing | -$502.03K |
| Net Cash Flow From Financing Activities | $5.28M |
| Net Cash Flow From Financing Activities, Continuing | $5.28M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$5.33M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.33M |
| Other Comprehensive Income/Loss | $0.00 |